Pentoxifylline: Evidence strong enough for renoprotection?

J Formos Med Assoc. 2016 Aug;115(8):591-2. doi: 10.1016/j.jfma.2015.12.010. Epub 2016 Jan 24.

Authors

Tai-Shuan Lai¹, Wen-Chih Chiang², Yung-Ming Chen³

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital, Bei-Hu Branch, Taipei, Taiwan, ROC.
² Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC.
³ Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan, ROC. Electronic address: chenym@ntuh.gov.tw.

PMID: 26817833
DOI: 10.1016/j.jfma.2015.12.010

No abstract available

MeSH terms

Diabetic Nephropathies / complications*
Humans
Kidney Failure, Chronic / drug therapy*
Pentoxifylline / therapeutic use*
Phosphodiesterase Inhibitors / therapeutic use*
Proteinuria / drug therapy*
Retrospective Studies
Taiwan

Substances

Phosphodiesterase Inhibitors
Pentoxifylline